Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients. Kulakova OG, Tsareva E Y, Boyko AN, Shchur SG, Gusev EI, Lvovs D, Favorov AV, Vandenbroeck K, Favorova OO Pharmacogenomics. 2012 Nov; 13(15):1689-700. PMID: 23171334. Abstract CommentRecommendBookmarkWatch